Cargando…

非小细胞肺癌淋巴结微转移的研究进展

The incidence and mortality of lung cancer rank top in China. One important factor is the occurrence of metastasis. With the development of science technology, the effect of surgical treatment on lung cancer is improved. Moreover, the use of targeted therapy has achieved a new height for the treatme...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058655/
https://www.ncbi.nlm.nih.gov/pubmed/30037376
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.08
_version_ 1783341737856466944
collection PubMed
description The incidence and mortality of lung cancer rank top in China. One important factor is the occurrence of metastasis. With the development of science technology, the effect of surgical treatment on lung cancer is improved. Moreover, the use of targeted therapy has achieved a new height for the treatment of lung cancer. However, the recurrence rate remains high even the tumor was completely resected at early stage. The occurrence of lymph node micrometastasis is considered as one of the plausible explanations. The difficulty indetecting micrometastasis has been greatly reduced. Although studies dig deeper into the lymph node micrometastasis, there are still some controversies including the selection of surgical procedures, the pathological staging and prognosis about patients with lymph node micrometastasis. This review manages to generalize the latest research progress of lymph node micrometastasis.
format Online
Article
Text
id pubmed-6058655
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60586552018-08-23 非小细胞肺癌淋巴结微转移的研究进展 Zhongguo Fei Ai Za Zhi 综述 The incidence and mortality of lung cancer rank top in China. One important factor is the occurrence of metastasis. With the development of science technology, the effect of surgical treatment on lung cancer is improved. Moreover, the use of targeted therapy has achieved a new height for the treatment of lung cancer. However, the recurrence rate remains high even the tumor was completely resected at early stage. The occurrence of lymph node micrometastasis is considered as one of the plausible explanations. The difficulty indetecting micrometastasis has been greatly reduced. Although studies dig deeper into the lymph node micrometastasis, there are still some controversies including the selection of surgical procedures, the pathological staging and prognosis about patients with lymph node micrometastasis. This review manages to generalize the latest research progress of lymph node micrometastasis. 中国肺癌杂志编辑部 2018-07-20 /pmc/articles/PMC6058655/ /pubmed/30037376 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.08 Text en 版权所有©《中国肺癌杂志》编辑部2018 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
非小细胞肺癌淋巴结微转移的研究进展
title 非小细胞肺癌淋巴结微转移的研究进展
title_full 非小细胞肺癌淋巴结微转移的研究进展
title_fullStr 非小细胞肺癌淋巴结微转移的研究进展
title_full_unstemmed 非小细胞肺癌淋巴结微转移的研究进展
title_short 非小细胞肺癌淋巴结微转移的研究进展
title_sort 非小细胞肺癌淋巴结微转移的研究进展
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058655/
https://www.ncbi.nlm.nih.gov/pubmed/30037376
http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.08
work_keys_str_mv AT fēixiǎoxìbāofèiáilínbājiéwēizhuǎnyídeyánjiūjìnzhǎn
AT fēixiǎoxìbāofèiáilínbājiéwēizhuǎnyídeyánjiūjìnzhǎn
AT fēixiǎoxìbāofèiáilínbājiéwēizhuǎnyídeyánjiūjìnzhǎn